2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution

IM Barbash, P Chouraqui, J Baron, MS Feinberg… - Circulation, 2003 - Am Heart Assoc
Background—Systemic delivery of bone marrow–derived mesenchymal stem cells (BM-
MSCs) is an attractive approach for myocardial repair. We aimed to test this strategy in a rat …

Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation

F Giordana, F D'Ascenzo, F Nijhoff, C Moretti… - The American journal of …, 2014 - Elsevier
The aim of this study was to identify predictors of 30-day and midterm mortality after
transcatheter aortic valve implantation (TAVI) by means of a systemic review. TAVI was …

Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?

J Leor, S Aboulafia-Etzion, A Dar, L Shapiro… - Circulation, 2000 - Am Heart Assoc
Background—The myocardium is unable to regenerate because cardiomyocytes cannot
replicate after injury. The heart is therefore an attractive target for tissue engineering to …

Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium

Y Amsalem, Y Mardor, MS Feinberg, N Landa, L Miller… - Circulation, 2007 - Am Heart Assoc
Background—Cell labeling with superparamagnetic iron oxide (SPIO) nanoparticles
enables noninvasive MRI and tracking of transplanted stem cells. We sought to determine …

The state of the excimer laser for coronary intervention in the drug-eluting stent era

S Badr, I Ben-Dor, D Dvir, IM Barbash… - Cardiovascular …, 2013 - Elsevier
OBJECTIVES: This study aims to determine how excimer laser coronary atherectomy
(ELCA) performs in the drug-eluting stent (DES) era. BACKGROUND: For more than …

Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction

S Etzion, A Battler, IM Barbash, E Cagnano… - Journal of molecular and …, 2001 - Elsevier
S. Etzion, A. Battler, IM Barbash, E. Cagnano, P. Zarin, Y. Granot, LH Kedes, RA Kloner and
J. Leor. Influence of Embryonic Cardiomyocyte Transplantation on the Progression of Heart …

Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart

J Leor, L Rozen, A Zuloff-Shani, MS Feinberg… - Circulation, 2006 - Am Heart Assoc
Background—Activated macrophages have a significant role in wound healing and
damaged tissue repair. We sought to explore the ability of ex vivo activated macrophages to …

Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation

IM Barbash, M Barbanti, J Webb… - European heart …, 2015 - academic.oup.com
Background The majority of transcatheter aortic valve implantation (TAVI) procedures are
currently performed by percutaneous transfemoral approach. The potential contribution of …

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement

IM Barbash, I Ben-Dor, D Dvir, G Maluenda, Z Xue… - American heart …, 2012 - Elsevier
BACKGROUND: Patients undergoing transcatheter aortic valve replacement (TAVR) are at
increased risk for acute kidney injury (AKI). The Valve Academic Research Consortium …